Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy

[1]  F. Dotta,et al.  Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes , 2019, International journal of molecular sciences.

[2]  F. Slack,et al.  Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In Vivo , 2019, Molecular therapy. Nucleic acids.

[3]  M. Helder,et al.  Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy , 2018, Artificial cells, nanomedicine, and biotechnology.

[4]  Semi Kim,et al.  Preparation of siRNA encapsulated nanoliposomes suitable for siRNA delivery by simply discontinuous mixing. , 2018, Biochimica et biophysica acta. Biomembranes.

[5]  Yun-jie He,et al.  Functional miRNAs in breast cancer drug resistance , 2018, OncoTargets and therapy.

[6]  Qingjie Ma,et al.  miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma , 2018, OncoTargets and therapy.

[7]  Masanori Kawano,et al.  MicroRNA-181c prevents apoptosis by targeting of FAS receptor in Ewing’s sarcoma cells , 2018, Cancer Cell International.

[8]  D. Rockey,et al.  Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice , 2018, Gastroenterology.

[9]  M. Helder,et al.  A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery , 2018, Artificial cells, nanomedicine, and biotechnology.

[10]  Zhaoxia Zhang,et al.  Evaluation of antitumor activity of survivin short interfering RNA delivered by lipid nanoparticles in colon cancer in vitro and in vivo , 2017, Oncology letters.

[11]  G. Calin,et al.  Non-coding RNAs: the cancer genome dark matter that matters! , 2017, Clinical chemistry and laboratory medicine.

[12]  K. Peter,et al.  Nanoliposomes for Safe and Efficient Therapeutic mRNA Delivery: A Step Toward Nanotheranostics in Inflammatory and Cardiovascular Diseases as well as Cancer , 2017, Nanotheranostics.

[13]  Qihong Huang,et al.  miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer , 2017, Scientific Reports.

[14]  Zhaoxia Zhang,et al.  Survivin downregulation using siRNA nanoliposomes inhibits cell proliferation and promotes the apoptosis of MHCC-97H hepatic cancer cells: An in vitro and in vivo study , 2017, Oncology letters.

[15]  Zhongyong Zhou,et al.  miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1 , 2017, OncoTargets and therapy.

[16]  Xing-Xing He,et al.  MiR‐101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma , 2017, Cancer medicine.

[17]  Jidong Zhang,et al.  Targeted Expression of miR-7 Operated by TTF-1 Promoter Inhibited the Growth of Human Lung Cancer through the NDUFA4 Pathway , 2016, Molecular therapy. Nucleic acids.

[18]  Srivatsan Kidambi,et al.  Targeted Delivery of MicroRNA125a-5p by Engineered Lipid Nanoparticles for the Treatment of HER2 Positive Metastatic Breast Cancer. , 2016, Journal of biomedical nanotechnology.

[19]  Robert J. Lee,et al.  Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded with MicroRNA-375 , 2016, Theranostics.

[20]  A. Chávez-Reyes,et al.  Therapeutic silencing of HPV 16 E7 by systemic administration of siRNA-neutral DOPC nanoliposome in a murine cervical cancer model with obesity. , 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[21]  Xiang Ma,et al.  Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes , 2015, International journal of nanomedicine.

[22]  H. Wong,et al.  Lipid-Based Nanocarriers for RNA Delivery , 2015, Current pharmaceutical design.

[23]  L. Pereira de Almeida,et al.  MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Youdong Chen,et al.  RETRACTED ARTICLE: MicroRNA-495 mimics delivery inhibits lung tumor progression , 2015, Tumor Biology.

[25]  R. Tekade,et al.  Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[26]  I. Kwon,et al.  Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancers. , 2014, Biotechnology advances.

[27]  Shimeng Liu,et al.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine. , 2014, Nanomedicine.

[28]  B. Moudgil,et al.  Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer , 2013, International journal of nanomedicine.

[29]  L. J. Lee,et al.  Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer , 2013, Molecular therapy. Nucleic acids.

[30]  J. Datta,et al.  Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  A. Bader,et al.  Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo , 2012, Leukemia.

[32]  Kenji Shimizu,et al.  Liposomal Delivery of MicroRNA-7–Expressing Plasmid Overcomes Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistance in Lung Cancer Cells , 2011, Molecular Cancer Therapeutics.

[33]  F. Slack,et al.  Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  Joshua T. Mendell,et al.  Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice , 2011, Molecular Cancer Therapeutics.

[35]  B. Liu,et al.  Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  K. Kelnar,et al.  Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. , 2010, Cancer research.

[37]  Peixuan Guo,et al.  Engineering RNA for Targeted siRNA Delivery and Medical Application , 2010, Advanced Drug Delivery Reviews.

[38]  Marilena Loizidou,et al.  Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. , 2009, Trends in pharmacological sciences.

[39]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[40]  Anil K Sood,et al.  Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. , 2005, Cancer research.

[41]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[42]  R. Müller,et al.  Nanostructured lipid matrices for improved microencapsulation of drugs. , 2002, International journal of pharmaceutics.

[43]  T. Kitagawa,et al.  A new cationic liposome for efficient gene delivery with serum into cultured human cells: a quantitative analysis using two independent fluorescent probes. , 2000, Biochimica et biophysica acta.

[44]  Kari Syrjänen,et al.  Comparison of Cell Proliferation and Toxicity Assays Using Two Cationic Liposomes , 1994, Pharmaceutical Research.

[45]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[46]  A. Bangham,et al.  A Correlation between Surface Charge and Coagulant Action of Phospholipids , 1961, Nature.

[47]  Gang Chen,et al.  The clinicopathological significance of decreased miR-125b-5p in hepatocellular carcinoma: evidence based on RT-qPCR, microRNA-microarray, and microRNA-sequencing. , 2019, International journal of clinical and experimental pathology.

[48]  J. Choi,et al.  Liposomes: versatile and biocompatible nanovesicles for efficient biomolecules delivery. , 2014, Journal of nanoscience and nanotechnology.

[49]  A. Bangham,et al.  NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE. , 1964, Journal of molecular biology.